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To the Editor: Although the pathogenesis of Takotsubo cardiomy-
opathy (TC) remains unclear, physical or emotional stress is
common in the majority of reported cases (1–3). The central role
for sympathetic stimulation in TC is suggested by elevations in
plasma catecholamines (1–3), neuronal imaging (2,4), and animal
studies (1,3). Takotsubo cardiomyopathy in rats as a result of
sympathetic stimulation was not reproducible following pretreat-
ment with beta-adrenergic blockade (1,3).
We present a patient with TC following exercise treadmill
testing, a situation known to have sympathetic overdrive. To
our knowledge, this is the first report during exercise and the
only one with perfusion imaging at the onset of the event. The
perfusion data are helpful to the understanding of the patho-
physiology of TC, and the presence of normal perfusion despite
characteristic wall motion abnormalities makes a strong point to
the primary role of metabolic changes rather than vascular
abnormalities.
A 71-year-old Caucasian woman underwent exercise sesta-
mibi imaging for evaluation of chest pain (CP). The physical
examination and electrocardiogram were normal (Fig. 1). The
patient achieved target heart rate, and Tc-99m sestamibi was
injected at 5 min when the patient began experiencing subster-
nal CP with ST-segment depression (Fig. 1). She was given 1
spray of nitroglycerin, and the ST-segment changes resolved
completely. Gated single-photon emission computed tomogra-
phy images obtained 1 h later were normal (Fig. 1C), but there
was dyskinesia of the apex (Fig. 1); the left ventricular ejection
fraction (LVEF) was 51%.
The patient’s CP subsided but did not disappear completely.
Coronary angiography was performed 3 h later and revealed no
obstructive coronary artery disease. The left ventriculogram was
abnormal (Fig. 2), and the LVEF was 55%. She did well at
follow-up 1 month later, and a 2-dimensional echocardiography
revealed normal LVEF with no regional wall motion abnormality.
The unique features in this patient are the temporal relation-
ship between TC and exercise and the normal perfusion pattern
at the onset of her event.
Perhaps TC results from stunning of the myocardium in the
setting of excess catecholamines, but whether this stunning is
due to ischemia and decreased perfusion on the basis of
microvascular vasoconstriction or due to a primary metabolic
abnormality is unknown (1– 4). One report showed a flow-
metabolism mismatch pattern; however, unlike that in coronary
artery disease, the pattern seen in TC showed relatively pre-
served flow but reduced glucose uptake (1). The perfusion
defects could be explained by a partial volume effect attributable
to stunning. Furthermore, this study could be faulted by the fact
that the imaging was obtained 3 days after the initial event,
but our patient showed normal perfusion even when the tracer
was injected at time zero.
A reduction in glucose uptake with normal perfusion has
been shown in humans and animals to be a feature of repetitive
stunning (1,4). Possible mechanisms include a decrease in the
activity of key enzymes of the glycolytic pathway or reduced
sensitivity to calcium in stunned myocardium with inhibition of
translocation of glucose transporter-4 from the intracellular
pool to the sarcolemma, thus reducing glucose uptake. Also,
excess catecholamines could lead to insulin resistance, which
may lead to impaired glucose uptake (1).
Other studies have shown a greater impairment in fatty acid
metabolism than perfusion in the mid and apical LV regions in
TC (4,5). The myocardium depends on a significant amount
(70% to 80%) of energy from fatty acid oxidation during aerobic
conditions, and there is a marked reduction in beta-oxidation of
fatty acids in the post-ischemic myocardium (5).
It seems that large-vessel spasm is an unlikely explanation of
TC in the vast majority of patients (1), and provocative
coronary vasospasm was induced in only 1 of 7 patients (6).
Abnormal Thrombolysis In Myocardial Infarction (TIMI)
frame counts have been described in all 3 major coronary
arteries in patients with TC, consistent with microvascular
rather than macrovascular impairment (3,5). Decreased coro-
nary flow velocity reserve and a reduction in deceleration time of
diastolic velocity of all 3 coronary arteries were demonstrated in
patients within 24 h of presentation. At 3-week follow-up,
these measurements improved, providing further evidence that
reversible microvascular dysfunction contributes to transient LV
dysfunction (3).
Other perfusion studies have shown moderate to severe
reductions in tracer uptake in affected LV segments in the
presence of normal angiographic coronary arteries (1,4 – 6).
Thus, while myocardial stunning is seen in TC, it remains poorly
understood whether the catecholamine excess leads to microvas-
cular spasm, direct myocyte toxicity secondary to cyclic adenosine
monophosphate-mediated calcium overload, or a primary meta-
bolic abnormality (1,2).
Perhaps the most enigmatic finding in patients with TC is
the predilection for dysfunction in the mid and apical segments
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of the LV with basal sparing (1,2). This characteristic finding is
likely due to basal-to-apical gradients in both perfusion and
sympathetic distribution (1–3). Sympathetic nerves and the density of
receptors are not uniformly distributed in the LV myocardium of dogs
and cats (3).
Finally, the most puzzling part of this syndrome is the very
high predilection in women and the rarity of recurrences,
despite the fact that stresses in life are rarely isolated. The role
of hormones and the possibility of misdiagnosis or inappropri-
ate diagnosis must be considered in future research projects.
Although metabolic changes or vascular abnormalities appear to
be the central causes of TC, the precise pathophysiology
remains uncertain.
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Figure 1 Exercise-Gated SPECT Imaging Results
(A) The patient’s baseline electrocardiogram in leads V5 and V6 reveals normal sinus rhythm without ST-segment changes suggestive of ischemia. (B) Electrocardiogram
during peak exercise and at the onset of substernal chest pressure shows 3 mm of ST-segment depression in V6. (C) The post-exercise single-photon emission com-
puted tomography (SPECT) sestamibi perfusion images demonstrates normal perfusion pattern. Three-dimensional gated SPECT images at end-diastole (D) and end-
systole (E), revealing apical dyskinesis (arrows).
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Letters to the Editor
Cardiovascular Mortality in
High-Risk Patients and T-786C
Polymorphism in Promoter
Region of the Endothelial Nitric
Oxide Synthase Gene
Rossi et al. (1) reported very interesting and intriguing results of
the first prospective study examining the possible effects of 2 single
nucleotide polymorphisms (SNP) in the endothelial nitric oxide
synthase (eNOS) gene (the T-786C SNP in the promoter region,
and the G894T SNP in exon 7) on cardiovascular mortality among
high-risk patients. Although no significant effects were found for
the G894T SNP, more cardiovascular deaths were found when
individuals with TT genotype for the T-786C SNP were com-
pared with CC  CT individuals (1). The significant effect of
T-786C SNP on cardiovascular mortality persisted even after
many confounding factors were taken into consideration. How-
ever, a significant number of individuals (32%) were on lipid-
lowering therapy at recruitment (1), and it is probable that an
increased proportion of these subjects may have received statins
thereafter.
Interestingly, although the T-786C SNP apparently does not
significantly affect nitric oxide (NO) availability (2,3), it may
modulate the responses to statins. In this regard, we have recently
reported that treatment with atorvastatin significantly increased
NO availability (measured as whole blood nitrite) in CC individ-
uals, but not in TT individuals (4), thus confirming previous
findings suggesting that statins may produce stronger effects on
NO availability in CC individuals compared with TT individ-
uals (5). In addition, atorvastatin significantly reduced the
concentrations of inflammatory markers in subjects with CC
(but not TT) genotype (6). Although these findings derive from
studies that included healthy individuals, they suggest that statins may
significantly modify the cardiovascular risk associated with the
T-786C SNP. Indeed, it is possible that treatment with statins
counteracts the effects associated with the T-786C SNP (4), thus
leading to apparently paradoxical results such as those reported by
Rossi et al. (1).
Figure 2 Contrast Left Ventriculography in the Right Anterior Oblique Projection
The left ventriculogram at end-diastole (A) and end-systole (B), showing apical ballooning and basal hyperkinesis.
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